Skip to main content

News

February 20, 2025

bioMérieux acquires Neoprospecta, a Brazil-based company dedicated to data and genomics solutions for microbial risk management in food and pharma industries

bioMérieux, a world leader in the field of in vitro diagnostics, has finalized the closing of the acquisition of Neoprospecta on January 29th, 2025. A Sale and Purchase Agreement (SPA) to acquire this Brasilian-based company was signed in November 2024. Neoprospecta, based in Florianopolis, develops and markets innovative user-friendly data and genomics solutions for augmenting quality assurance programs and improve microbiological risk prevention in food and pharma industries.
Discover More

  • February 27, 2023

    2022: a fruitful year of CSR achievements

    We are committed to play our part and as every gesture counts to change the game, we have implemented a number of concrete actions in line with our CSR objectives.
    Read more

  • August 02, 2022

    Our EcoVadis Score Increases by 3 Points This Year !

    For the third consecutive year, we are awarded a Platinum medal, the highest level distinguishing bioMérieux as part of the Top 1%.
    Read more

  • July 29, 2022

    CO2 emissions: bioMérieux is switching to renewable energy

    Doing our part to help reduce CO2 emissions through renewable energy.
    Read more

  • July 01, 2022

    11 of Our Best Channel Partners Invited in Lyon, France

    We were very happy to have rewarded 11 of our most performing Channel Partners with a week in Marcy l'Etoile, France, in our HQ.
    Read more